Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines

Cell Growth and Differentiation

Volumn 8, Issue 5, 1997, Pages 599-609

  Szekely, Laszlo ^a   Pokrovskaja, Katja ^a   Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL IMMORTALIZATION; CYTOSKELETON; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

BURKITT LYMPHOMA; CELL LINE, TRANSFORMED; CELL NUCLEUS; CELL TRANSFORMATION, VIRAL; CYTOSKELETON; HERPESVIRUS 4, HUMAN; HUMANS; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 0030948816     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Calender, A., Cordier, M., Billaud, M., and Lenoir, G. M. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV). Int. J. Cancer, 46: 658-663, 1990.
2. Cheah, M. S., Ley, T. J., Tronick, S. R., and Robbins, K. C. fgr protooncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection. Nature (Lond.), 319: 238-240, 1986.
3. Okano, M., Davis, J. R., Brichacek, B., Yasuda, N., and Purtilo, D. T. Early activation of the proto-oncogene c-fgr during Epstein-Barr virus immortalization. Cancer Lett., 64: 11-15, 1992.
4. Alfieri, C., Birkenbach, M., and Kieff, E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology, 181: 595-608, 1991.
5. Hollyoake, M., Stuhler, A., Farrell, P., Gordon, J., and Sinclair, A. The normal cell cycle activation program is exploited during the infection y of quiescent B lymphocytes by Epstein-Barr virus. Cancer Res., 55: 4784-4787, 1995.
6. Szekely, L., Pokrovskaja, K., Jiang, W. Q., Selivanova, G., Lowbeer, M., Ringertz, N., Wiman, K. G., and Klein, G. Resting B cells, EBV-infected B blasts, and established lymphoblastoid cell lines differ in their rb, p53, and EBNA-5 expression patterns. Oncogene, 10: 1869-1874, 1995.
7. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J., 13: 3321-3328, 1994.
8. Pokrovskaja, K., Ehlin-Henriksson, B., Bartkova, J., Bartek, J., Scuderi, R., Szekely, L., Wiman, K. G., and Klein, G. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived cell lines. Cell Growth & Differ., 7: 1723-1732, 1996.
9. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65: 1107-1115, 1991.
10. Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G., and Kieff, E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol., 67: 2209-2220, 1993.
11. Cohen, J. I., Wang, F., Mannick, J., and Kieff, E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA, 86: 9558-9562, 1989.
12. Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A., and Kieff, E. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol., 65: 6826-6837, 1991.
13. Tomkinson, B., and Kieff, E. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Viral., 66: 2893-2903, 1992.
14. Tomkinson, B., Robertson, E., and Kieff, E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67: 2014-2025, 1993.
15. Jiang, W. Q., Szekely, L., Wendel-Hansen, V., Ringertz, N., Klein, G., and Rosen, A. Colocalization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp. Cell Res., 197: 314-318, 1991.
16. Szekely, L., Jiang, W. Q., Pokrovskaja, K., Wiman, K. G., Klein, G, and Ringertz, N. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp7O proteins after exposure to heat shock or cell density congestion. J. Gen. Virol., 76: 2423-2432, 1995.
17. Szekely, L., Pokrovskaja, K., Jiang, W. Q., Dethe, H., Ringertz, N., and Klein, G. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol., 70: 2562-2568, 1996.
18. Szekely, L., Pokrovskaja, K., Jiang, W. Q., de The, H., Ringertz, N., and Klein, G. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol., 70: 2562-2568, 1996.
19. Hozak, P., Hassan, A. B., Jackson, D. A., and Cook, P. R. Visualization of replication factories attached to nucleoskeleton. Cell, 73: 361-373, 1993.
20. Hozak, P., Jackson, D. A., and Cook, P. R. Replication factories and nuclear bodies: the ultrastructural characterization of replication sites during the cell cycle. J. Cell Sci., 107: 2191-2202, 1994.
21. Jackson, D. A., and Cook, P. R. Transcription occurs at a nucleoskeleton. EMBO J., 4: 919-925, 1985.
22. Thorburn, A., and Knowland, J. Attachment of vitellogenin genes to the nucleoskeleton accompanies their activation. Biochem. Biophys. Res. Commun., 191: 308-313, 1993.
23. Hozak, P., Cook, P. R., Schofer, C., Mosgoller, W., and Wachtler, F. Site of transcription ribosomal RNA and intranucleolar structure in HeLa cells. J. Cell Sci., 107: 639-648, 1994.
24. Jackson, D. A., and Cook, P. R. Visualization of a filamentous nucleoskeleton with a 23-nm axial repeat. EMBO J., 7: 3667-3677, 1988.
25. Hozak, P., Sasseville, A. M., Raymond, Y., and Cook, P. R. Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J. Cell Sci., 108: 635-644, 1995.
26. Kamei, H. A nuclear dot-like structure that has a relationship with perinuclear intermediate filaments. Exp. Cell Res., 218: 155-165, 1995.
27. Georgatos, S. D., and Blobel, G. Lamin B constitutes an intermediate filament attachment site at the nuclear envelope. J. Cell Biol., 105: 117-125, 1987.
28. Georgatos, S. D., and Marchesi, V. T. The binding of vimentin to human erythrocyte membranes: a model system for the study of intermediate filament-membrane interactions. J. Cell Biol., 100: 1955-1961, 1985.
29. Bilbe, G., Delabie, J., Bruggen, J., Richener, H., Asselbergs, F. A., Cerletti, N., Sorg, C., Odink, K., Tarcsay, L., Wiesendanger, W. Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. EMBO J., 11: 2103-2113, 1992.
30. Delabie, J., Shipman, R., Bruggen, J., De Strooper, B., van Leuven, F., Tarcsay, L., Cerletti, N., Odink, K., Diehl, V., Bilbe, G. Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large cell lymphoma. Blood, 80: 2891-2896, 1992.
31. Delabie, J., Bilbe, G., Bruggen, J., Van Leuven, F., and De Wolf-Peeters, C. Restin in Hodgkin's disease and anaplastic large cell lymphoma. Leuk. Lymphoma, 12: 21-26, 1993.
32. Kelly, M. M., Phanhthourath, C., Brees, D. K., McCabe, C. F., and Cole, G. J. Molecular characterization of EAP-300: a high molecular weight, embryonic polypeptide containing an amino acid repeat comprised of multiple leucine-zipper motifs. Dev. Brain Res., 85: 31-47, 1995.
33. Duval, M., Ma, X. Y., Valet, J. P., and Vincent, M. Purification of developmentally regulated avian 400-kDa intermediate filament associated protein: molecular interactions with intermediate filament proteins and other cytoskeleton components. Biochem. Cell Biol. 73: 651-657, 1995.
34. Chabot, P., and Vincent, M. Transient expression of an intermediate filament-associated protein (IFAPa-400) during in vivo and in vitro differentiation of chick embryonic cells derived from neuroectoderm. Dev. Brain Res., 54: 195-204, 1990.
35. Yang, H. Y., Lieska, N., Glick, R., Shao, D., and Pappas, G. D. Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes. Proc. Natl. Acad. Sci. USA, 90: 8534-8537, 1993.
36. Skalli, O., Chou, Y. H., and Goldman, R. D. Cell cycle-dependent changes in the organization of an intermediate filament-associated protein: correlation with phosphorylation by p34cdc2. Proc. Natl. Acad. Sci. USA, 89: 11959-11963, 1992.
37. Guy, G. R., and Gordon, J. Epstein-Barr virus and a tumour-promoting phorbol ester use similar mechanisms in the stimulation of human B-cell proliferation. Int. J. Cancer, 43: 703-708, 1989.
38. Laszlo, L., Tuckwell, J., Self, T., Lowe, J., Landon, M., Smith, S., Hawthorne, J. N., and Mayer, R. J. The latent membrane protein-1 in Epstein-Barr virus-transformed lymphoblastoid cells is found with ubiquitin-protein conjugates and heat-shock protein 70 in lysosomes oriented around the microtubule organizing centre. J. Pathol., 164: 203-214, 1991.
39. Birkenbach, M., Liebowitz, D., Wang, F., Sample, J., and Kieff, E. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J. Virol., 63: 4079-4084, 1989.
40. Silins, S. L., and Sculley, T. B. Modulation of vimentin, the CD40 activation antigen, and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4. Virology, 202: 16-24, 1994.
41. Lilienbaum, A., Legagneux, V., Portier, M. M., Dellagi, K., and Paulin, D. Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells. EMBO J, 5: 2809-2814, 1986.
42. Finke, J., Rowe, M., Kallin, B., Ernberg, I., Rosen, A., Dillner, J., and Klein, G. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol., 61: 3870-3878, 1987.
43. Spitz, M., Spitz, L., Thorpe, R., and Eugui, E. Intrasplenic primary immunization for the production of monoclonal antibodies. J. Immunol. Methods, 70: 39-43, 1984.
44. Harlow, E., and Lane, D. Antibodies. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
45. 1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell, 65: 381-393, 1991.
46. Szekely, L., Jiang, W. Q., Bulic-Jakus, F., Rosen, A., Ringertz, N., Klein, G., and Wiman, K. G. Cell type and differentiation-dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth & Differ., 3: 149-156, 1992.
47. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G., and Wiman, K. G. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA, 90: 5455-5459, 1993.